英期刊：服阿斯匹靈可治癌
<p style="line-height: 150%; margin: 0cm 0cm 0pt;" class="MsoNormal"><span style="LINE-HEIGHT: 150%; FONT-FAMILY: '新細明體','serif'; COLOR: dimgray; FONT-SIZE: 10pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">【聯合報</span><span style="LINE-HEIGHT: 150%; FONT-FAMILY: 細明體; COLOR: dimgray; FONT-SIZE: 10pt; mso-bidi-font-family: 細明體; mso-font-kerning: 0pt" lang="EN-US">╱</span><span style="line-height: 150%; font-family: '新細明體','serif'; color: dimgray; font-size: 10pt;">編譯馮克芸、陳俐君／報導】</span></p><p style="LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan" class="MsoNormal"><br><span style="LINE-HEIGHT: 150%; FONT-FAMILY: '新細明體','serif'; COLOR: dimgray; FONT-SIZE: 10pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt"></span><span style="LINE-HEIGHT: 150%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: dimgray; FONT-SIZE: 10pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體" lang="EN-US"><o:p></o:p></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">三項發表在英國著名醫學期刊上的研究，為阿斯匹靈的抗癌效果提供了最新例證：每天服用低劑量阿斯匹靈，只要三到五年，不只可以防癌，甚至可以治療癌症、降低癌症轉移的可能性。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">不過，台大醫院雲林分院心血管中心主任王宗道說，長期吃阿斯匹靈可能有胃潰瘍、腸胃出血等副作用，目前只建議心血管疾病患者使用，不建議健康民眾吃，以免防癌、抗癌或防心血管疾病不成，反倒先傷胃。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">英國廣播公司（ＢＢＣ）報導，許多人已服用阿斯匹靈作為心臟藥，然而英國牛津大學教授魯斯威爾（</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體" lang="EN-US">Peter Rothwell</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">）在最新研究中，已把「降低某些癌症的風險」和「服用阿斯匹靈」連結在一起，特別是腸癌。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">魯斯威爾是國際知名的阿斯匹靈專家，他的團隊先前的研究顯示，人們得服用阿斯匹靈大約十年，才能有防癌效果，但現在他們認為，阿斯匹靈的保護作用會在三到五年之內發生。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">而且，阿斯匹靈似乎不只降低許多不同種類癌症的發生風險，還可能阻止癌細胞在人體擴散。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">魯斯威爾團隊的研究，根據的是五十一項試驗的資料，參與試驗的病患超過七萬七千人，這些試驗是設計用來比較兩種情況的預防心臟疾病效果：一是服用阿斯匹靈，二是不服用任何藥物。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">當檢視這些病患中有多少人罹癌且死於癌症時，魯斯團隊發現，這項數據也與是否服用阿斯匹靈有關。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">他們的具體發現是：每天服用低劑量阿斯匹靈，即七十五到三百毫克，只要三年，癌症病例就會減少約四分之一，五年內還可降低癌症死亡風險百分之十五。若是劑量提高到每天服用三百毫克以上，不到三年即可降低癌症死亡風險百分之十五。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">如果病患服用阿斯匹靈五年以上，則癌症死亡風險減幅更大，達百分之卅七。另外，服用低劑量阿斯匹靈的腸癌病患，五人就有一人可防止癌細胞擴散。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>
<p style="LINE-HEIGHT: 190%; MARGIN: 0cm 0cm 0pt; WORD-BREAK: break-all; mso-pagination: widow-orphan; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class="MsoNormal"><span style="LINE-HEIGHT: 190%; FONT-FAMILY: '新細明體','serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-bidi-font-family: Arial; mso-font-kerning: 0pt">這三項最新研究中，有兩項發表在廿一日出刊的醫學期刊「刺胳針」，另一項發表在「刺胳針腫瘤學」。但有專家警告，目前的證據尚不足以建議服用阿斯匹靈來預防癌症，且阿斯匹靈會造成胃出血之類的危險副作用。</span><span style="LINE-HEIGHT: 190%; FONT-FAMILY: 'Arial','sans-serif'; COLOR: #414141; FONT-SIZE: 11.5pt; mso-font-kerning: 0pt; mso-fareast-font-family: 新細明體"> <span lang="EN-US"><o:p></o:p></span></span></p>